SLU-PP-332 (5mg)
Login to view prices.
.Existing research has found the following:
-
Supports Metabolic Activation Research – Studied for its potential to induce mitochondrial uncoupling and enhance cellular energy expenditure.
-
Explores Fat Reduction Mechanisms – Investigated for reducing adipose accumulation and promoting fat oxidation in pre-clinical models.
-
Evaluates Body Composition Effects – Examined for preserving lean muscle mass while supporting targeted fat loss in experimental settings.
Description
Endurance and Performance-Capacity Research
-
SLU-PP-332 is a small-molecule mitochondrial uncoupler studied in pre-clinical models for its ability to increase endurance capacity and oxidative efficiency. Experimental data demonstrate that treated animals exhibited ~50% longer running duration and distance versus controls, making it valuable for studying muscular-endurance physiology and mitochondrial bioenergetics.
Adiposity and Weight-Regulation Models
-
In animal trials, SLU-PP-332 administration led to reduced body-weight gain and lower adipose accumulation despite unchanged caloric intake, allowing investigation into energy-balance and lipid-metabolism regulation mechanisms.
Metabolic-Health and Fat-Oxidation Studies
-
SLU-PP-332 has been observed to enhance fatty-acid oxidation and basal energy expenditure in non-clinical systems, providing a model for metabolic-rate and thermogenic-pathway research.
Skeletal-Muscle Composition and Fiber-Type Modulation
-
Research indicates SLU-PP-332 promotes a shift toward oxidative (type I) muscle fibers, which are more fatigue-resistant. This makes it a useful compound for examining mitochondrial biogenesis, muscle-fiber differentiation, and endurance adaptation.
Mitochondrial Function and Cellular-Energy Dynamics
-
By inducing mild mitochondrial uncoupling, SLU-PP-332 increases oxygen consumption and ATP turnover efficiency, supporting exploration of mitochondrial signaling, metabolic flexibility, and energy-homeostasis studies.
Systemic-Metabolism and Disease-Mechanism Models
-
Owing to its metabolic and muscle-adaptation properties, SLU-PP-332 has been investigated in pre-clinical studies addressing obesity, insulin resistance, age-related sarcopenia, and heart-failure models, providing insight into energy-linked disease states.
Concentration: ≥98%
Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding endurance, fat loss, or metabolic enhancement in humans. End-user assumes responsibility for determining suitability for specific research protocols.
